Search Results - "Kotch, Chelsea"
-
1
Neurofibromatosis type 1-associated gliomas and other tumors: A new pathway forward?
Published in Pediatric hematology oncology journal (01-06-2023)“…Neurofibromatosis type 1 (NF1) is an autosomal dominant cancer predisposition syndrome caused by germline alterations of the NF1 gene. Patients with NF1 are at…”
Get full text
Journal Article -
2
Life-threatening altered mental status secondary to memantine in an adolescent undergoing cranial radiotherapy for medulloblastoma
Published in Journal of oncology pharmacy practice (01-03-2023)“…Introduction Memantine is used for neurocognitive protection in patients undergoing cranial radiotherapy for central nervous system tumors and is reported to…”
Get full text
Journal Article -
3
P588: Identification of NF1-associated tumor mutations in plasma cfDNA and its clinical application
Published in Genetics in Medicine Open (2023)Get full text
Journal Article -
4
Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome
Published in Expert review of clinical immunology (03-08-2019)“…: Cancer-directed immunotherapies are transforming the landscape in oncology as new and exciting therapies move from the laboratory to the bedside. Chimeric…”
Get more information
Journal Article -
5
A 7-month-old with Fever and Facial Palsy
Published in Pediatrics in review (01-10-2020)Get full text
Journal Article -
6
The Impact of Proactive Gastrostomy Tube Placement on Treatment-related Outcomes in Young Children With High-grade Central Nervous System Tumors
Published in Journal of pediatric hematology/oncology (08-06-2023)“…Young children undergoing treatment with intensive chemotherapy for high-grade central nervous system (CNS) tumors are at risk for malnutrition, yet no…”
Get full text
Journal Article -
7
Retrospective Cohort Analysis of the Impact of Puberty on Plexiform Neurofibroma Growth in Patients with Neurofibromatosis Type 1
Published in The Journal of pediatrics (01-09-2023)“…To assess the hypothesis that plexiform neurofibroma (PN) growth rates increase during puberty. PN growth rates before and during puberty were compared in a…”
Get full text
Journal Article -
8
-
9
LGG-55. DIFFERENTIAL TOXICITY PROFILE OF INDIVIDUAL MEK INHIBITORS: A MULTI-INSTITUTION RETROSPECTIVE REVIEW
Published in Neuro-oncology (Charlottesville, Va.) (18-06-2024)Get full text
Journal Article -
10
NFS-18. LOWER BODY SURFACE AREA IS ASSOCIATED WITH INCREASED LIKELIHOOD OF PLEXIFORM NEUROFIBROMA RESPONSE TO MEK INHIBITION
Published in Neuro-oncology (Charlottesville, Va.) (18-06-2024)Get full text
Journal Article -
11
Low-grade glioma in children with neurofibromatosis type 1: surveillance, treatment indications, management, and future directions
Published in Child's nervous system (01-10-2024)“…Neurofibromatosis type 1 (NF1) is an autosomal dominant cancer predisposition syndrome characterized by the development of both central and peripheral nervous…”
Get full text
Journal Article -
12
The Impact of Proactive Gastrostomy Tube Placement on Treatment-related Outcomes in Young Children With High-grade Central Nervous System Tumors
Published in Journal of pediatric hematology/oncology (01-08-2023)“…Young children undergoing treatment with intensive chemotherapy for high-grade central nervous system (CNS) tumors are at risk for malnutrition, yet no…”
Get full text
Journal Article -
13
Conservative Management of Alloimmune Hemolysis and Cholestasis With Extreme Laboratory Abnormalities
Published in Pediatrics (Evanston) (01-02-2021)“…Alloimmune hemolytic disease of the fetus or newborn (HDFN) is a rare cause of neonatal cholestasis. HDFN-associated cholestasis has most often been reported…”
Get full text
Journal Article -
14
eP058 - Atypical teratoid rhabdoid tumor in a child with neurofibromatosis type 2: a novel dual diagnosis
Published in Molecular genetics and metabolism (01-04-2021)Get full text
Journal Article -
15
Atypical teratoid rhabdoid tumor in a child with neurofibromatosis type 2: a novel dual diagnosis
Published in Molecular genetics and metabolism (01-04-2021)Get full text
Journal Article -
16
The impact of changes in gadolinium-enhancement on disease progression in children with neurofibromatosis type 1-associated optic pathway glioma: a retrospective analysis
Published in Journal of neuro-oncology (01-09-2023)“…Purpose There has been limited investigation of imaging features associated with visual acuity (VA) decline and initiation of treatment for patients with…”
Get full text
Journal Article -
17
Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1
Published in Neuro-oncology (Charlottesville, Va.) (01-08-2022)“…Abstract Background Nearly one-third of patients with neurofibromatosis type 1-associated optic pathway glioma (NF1-OPG) fail frontline chemotherapy; however,…”
Get full text
Journal Article -
18
Expanding the MOG phenotype: Brainstem encephalitis with punctate and curvilinear enhancement
Published in Neurology : neuroimmunology & neuroinflammation (01-11-2019)Get full text
Journal Article -
19
Atypical teratoid rhabdoid tumor in a child with neurofibromatosis type 2: A novel dual diagnosis
Published in Cancer genetics (01-04-2022)“…•Pathogenic germline NF2 mutation was identified in a patient with atypical teratoid rhabdoid tumor.•Chromosome with germline deletion of NF2 acquired a…”
Get full text
Journal Article -
20
Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study
Published in Cancers (05-05-2023)“…Limited therapies exist for neurofibromatosis type 1 (NF1)-associated plexiform neurofibroma (PN). For this reason, the activity of vinblastine (VBL) and…”
Get full text
Journal Article